Research
Metabolic adaptation
GB participants used fewer glucose-lowering medications at 10 years, but HbA1c, fasting glucose, calculated cardiovascular risk, quality-of-life, and incident diabetes complications did not differ significantly between the groups.
While GB surgery may reduce the need for glucose-lowering medications, it does not significantly improve other health metrics.
StrongQualifiesmedium confidence
GB participants used fewer glucose-lowering medications at 10 years but HbA1c, fasting glucose, calculated cardiovascular risk, quality-of-life and incident diabetes complications did not differ significantly between the groups.
Why this rating
Based on randomized trial design.
Source
Long‐term impact of weight loss for people with overweight but not obesity, and with type 2 diabetes: 10‐year outcomes of a randomized trial of gastric band surgery
Qi Yang Damien Qi et al. · Diabetes Obesity and Metabolism · 2023
rct · n=51Cited 12×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →